BRIDGEBIO SHARES DATA ON SERUM TTR INCREASE WHEN SWITCHING PARTICIPANTS FROM PLACEBO AND TAFAMIDIS TO ACORAMIDIS IN ATTRIBUTE-CM AND ITS OPEN-LABEL EXTENSION

Reuters · 08/30/2024 14:50

Please log in to view news